Anti-N-methyl-D-Aspartate-Receptor Encephalitis in a Four-Year-Old Girl - 07/03/14
Doi : 10.1016/j.jpeds.2009.07.057
Roberta Biancheri, MD, PhD a, ⁎ 
, Alice Pessagno, MD a, Maria Giuseppina Baglietto, MD, PhD a, Sarosh R. Irani, MRCP c, Andrea Rossi, MD b, Gaia Giribaldi, MD a, Marisol Mirabelli Badenier, MD a, Angela Vincent, FRCP c, Edvige Veneselli, MD a
, Alice Pessagno, MD a, Maria Giuseppina Baglietto, MD, PhD a, Sarosh R. Irani, MRCP c, Andrea Rossi, MD b, Gaia Giribaldi, MD a, Marisol Mirabelli Badenier, MD a, Angela Vincent, FRCP c, Edvige Veneselli, MD a a Child Neurology and Psychiatry Unit, G. Gaslini Institute and University of Genova, Genova, Italy
b Pediatric Neuroradiology, G. Gaslini Institute, Genova, Italy
c Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
Reprint requests: Roberta Biancheri, MD, PhD, Child Neurology and Psychiatry. IRCCS G. Gaslini, Largo G. Gaslini 5, 16147 Genova, Italy.Abstract |
Anti-N-methyl-D-aspartate-receptor encephalitis is a recently identified autoimmune disorder. We report on a 4-year-old girl presenting with seizures after nonspecific viral-like symptoms, progressing to severe aphasia, upper limb dyskinesias, fluctuation in consciousness, and inability to walk. Anti-N-methyl-D-aspartate-receptor encephalitis should be included in the differential diagnosis of acute/subacute encephalitis in children.
Le texte complet de cet article est disponible en PDF.Mots-clés : CSF, EEG, FLAIR, IVIG, MRI, NMDAR
Plan
| The authors declare no conflicts of interest. |
© 2010
Mosby, Inc. Tous droits réservés.
Vol 156 - N° 2
P. 332-334 - février 2010 Retour au numéro
Article précédent
- Failure of Resolution of Portal Fibrosis during Omega-3 Fatty Acid Lipid Emulsion Therapy in Two Patients with Irreversible Intestinal Failure
- Jason S. Soden, Mark A. Lovell, Kristin Brown, David A. Partrick, Ronald J. Sokol
- Recent Experience in the Treatment of Diarrhea in Infants : Darrow DC, Welsh JS. J Pediatr 1960;56:204-10
- J. Marc Rhoads
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?